199 related articles for article (PubMed ID: 3931944)
1. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
[TBL] [Abstract][Full Text] [Related]
2. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF.
von Werder K; Losa M; Stalla GK; Bock L; Müller OA
Acta Neurochir (Wien); 1985; 75(1-4):81-7. PubMed ID: 2986424
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects.
Losa M; Schopohl J; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1985 Aug; 109(4):467-73. PubMed ID: 3929513
[TBL] [Abstract][Full Text] [Related]
4. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone releasing factor (hpGRF)-stimulation test in normal controls and acromegalic patients.
von Werder K; Müller OA; Hartl R; Losa M; Stalla GK
J Endocrinol Invest; 1984 Jun; 7(3):185-91. PubMed ID: 6432889
[TBL] [Abstract][Full Text] [Related]
6. Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration.
Sartorio A; Spada A; Bochicchio D; Atterrato A; Morabito F; Faglia G
Neuroendocrinology; 1986; 44(4):470-4. PubMed ID: 3102991
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF (1-44) ) in acromegaly and hypopituitarism.
Wood SM; Ch'ng JL; Adams EF; Webster JD; Joplin GF; Mashiter K; Bloom SR
Br Med J (Clin Res Ed); 1983 May; 286(6379):1687-91. PubMed ID: 6405935
[TBL] [Abstract][Full Text] [Related]
8. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
Watanobe H; Tamura T; Sasaki S; Takebe K
Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone responses to hp GRF 1-44 amide, bromocriptine and stress in acromegaly are correlated.
Belchetz PE
Postgrad Med J; 1987 Apr; 63(738):241-4. PubMed ID: 3120167
[TBL] [Abstract][Full Text] [Related]
10. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
[TBL] [Abstract][Full Text] [Related]
11. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone releasing factor infusion does not sustain elevated GH-levels in normal subjects.
Losa M; Bock L; Schopohl J; Stalla GK; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1984 Dec; 107(4):462-70. PubMed ID: 6440392
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone.
Faglia G; Paracchi A; Ferrari C; Beck-Peccoz P
Clin Endocrinol (Oxf); 1978 May; 8(5):373-80. PubMed ID: 417883
[TBL] [Abstract][Full Text] [Related]
14. Effect of synthetic ovine corticotropin-releasing factor on growth hormone secretion in patients with acromegaly.
Tanaka K; Watabe T; Yoshida H; Shimizu N
Endocrinol Jpn; 1984 Jun; 31(3):355-61. PubMed ID: 6094167
[TBL] [Abstract][Full Text] [Related]
15. The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly.
Giusti M; Lomeo A; Mazzocchi G; Mignone D; Sessarego P; Monachesi M; Giordano G
J Endocrinol Invest; 1985 Jun; 8(3):203-6. PubMed ID: 3928732
[TBL] [Abstract][Full Text] [Related]
16. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
17. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.
Biermasz NR; Smit JW; van Dulken H; Roelfsema F
Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjects.
Jordan V; Dieguez C; Valcavi R; Artioli C; Portioli I; Rodriguez-Arnao MD; Gomez-Pan A; Hall R; Scanlon MF
Clin Endocrinol (Oxf); 1986 Apr; 24(4):415-20. PubMed ID: 2874906
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
Watanobe H; Tamura T
Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355
[TBL] [Abstract][Full Text] [Related]
20. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
Gelato MC; Merriam GR; Vance ML; Goldman JA; Webb C; Evans WS; Rock J; Oldfield EH; Molitch ME; Rivier J
J Clin Endocrinol Metab; 1985 Feb; 60(2):251-7. PubMed ID: 3917454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
